1-3 of 3
Brian M Freed, PhD, DABHI
Close
Sort by
Journal Articles

Class II HLA Epitope Level Mismatch Can Predict Chronic Graft-Versus-Host Disease and Survival Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide

Scott R Solomon, MD, Michael T Aubrey, CHS, Cheri Anobile, Xu Zhang, PhD, Brian M Freed, PhD DABHI, Lawrence E Morris, MD, H. Kent Holland, MD, Melhem Solh, MD, Asad Bashey, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 311.
https://doi.org/10.1182/blood-2018-99-114122
Published: 2018
Journal Articles

Selecting the Best Donor for T Cell-Replete Haploidentical Transplantation: Importance of HLA Disparity, NK Alloreactivity, and Other Clinical Variables

Scott R Solomon, MD, Michael A Aubrey, CHS, Xu Zhang, PhD, Allison Piluso, Brian M Freed, PhD DABHI, Stacey Brown, CCRP, Katelin C Jackson, Melhem M Solh, MD, Lawrence E Morris, MD, H. Kent Holland, MD, Asad Bashey, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 670.
https://doi.org/10.1182/blood.V130.Suppl_1.670.670
Published: 2017
Journal Articles

Measurement of Stem Cell Potency, Assessment of Acceptance Limits for Release Criteria and Prediction of Umbilical Cord Blood Engraftment Using a Replacement for the Colony-Forming Cell Assay

Ivan N. Rich, PhD, Karen Hall, MT(ASCP), Holli Harper, MS, Brian M Freed, PhD, DABHI
Journal: Blood
Blood (2008) 112 (11): 3474.
https://doi.org/10.1182/blood.V112.11.3474.3474
Published: 2008